Liu, M., Ding, J., Peng, Y., Fang, J., Zhao, M., Zhang, W., et al
As the first telomerase-activating anti-aging drug, Epitalon signifies a shift from symptom-based treatments to mechanism-driven interventions, potentially extending human healthspan
Other risk groups include older adults, pregnant women, people taking metformin or long-term acid-suppressing medications (PPIs, H2 blockers), those with conditions affecting the gastrointestinal tract (pernicious anaemia, Crohn's disease, coeliac disease), and individuals who have undergone gastric or ileal surgery
These findings suggested that our peptide exhibited potent functionality within cells as a senolytic drug with selectivity for senescent cells